The BabySeq Project: Genomic Sequencing for Childhood Risk and Newborn Illness (U19 HD077671) is a first - of - its - kind
randomized clinical trial designed to examine how best to use genomics in clinical pediatric medicine by creating and safely testing methods for integrating sequencing into the care of newborns.
As one of the of the center's research projects, Dr. Kent P. Hymel, a child abuse pediatrician at Penn State Children's Hospital, will lead eight pediatric intensive care units from across the country in
a randomized clinical trial designed to assess the impact of a novel screening tool for pediatric abusive head trauma.
Not exact matches
His primary research interests since 1996 have been in the
design and conduct of a number of
randomized trials in
clinical obstetrics and perinatology.
At The Fertility Center of Las Vegas, each
clinical trial is
designed as a prospective,
randomized study.
Although some SIDS experts and policy - makers endorse pacifier use recommendations that are similar to those of the AAP, 272,273 concerns about possible deleterious effects of pacifier use have prevented others from making a recommendation for pacifier use as a risk reduction strategy.274 Although several observational studies275, — , 277 have found a correlation between pacifiers and reduced breastfeeding duration, the results of well -
designed randomized clinical trials indicated that pacifiers do not seem to cause shortened breastfeeding duration for term and preterm infants.278, 279 The authors of 1 study reported a small deleterious effect of early pacifier introduction (2 — 5 days after birth) on exclusive breastfeeding at 1 month of age and on overall breastfeeding duration (defined as any breastfeeding), but early pacifier use did not adversely affect exclusive breastfeeding duration.
So Szmulewitz and colleague Mark Ratain, MD, the Leon O. Jacobson professor of medicine and director of the Center for Personalized Therapeutics at the University of Chicago Medicine,
designed a
randomized clinical trial to see if the drug could be used more efficiently and at less expense.
Since
randomized clinical trials — the gold - standard in research — don't accommodate patients» preferences, Zoellner and her research team used a study
design called a «doubly
randomized preference
trial» to investigate whether giving patients a choice affects their treatment outcomes.
The determination of each efficacy level was also based on the rigor and quantity of published studies on the drug class: to be in Level A, for example, a class of drugs must have been supported by at least two «Class I» studies — well -
designed, double - blind,
randomized, placebo - controlled
clinical trials.
Using a
randomized, placebo - controlled
clinical trial (RCT)
design, they
randomized 48 participants into four equal groups of 12 people: low - to - moderate intensity, high - volume aerobic exercise (LO: HI); high - intensity, low - volume aerobic exercise (HI: LO); low - to - moderate intensity, low - volume aerobic exercise (LO: LO); and placebo (PLA) for an eight - week period.
In the $ 1.47 million, four - year grant called â $ œBiomarkers of Ischemic Outcomes in Intracranial Stenosisâ $ (BIOSIS), Emory researchers are analyzing blood samples from 451 patients from around the country who were enrolled in a study known as SAMMPRIS (Stenting and Aggressive Medical Management for Preventing Recurrent stroke in Intracranial Stenosis), the first
randomized, multicenter
clinical trial designed to test whether stenting intracranial arteries would prevent recurrent stroke.
Scientific contributions include publication of the first
randomized trials to assess the impact of common complex genetic risk markers, empirically measuring the outcomes of DTC genetic testing,
design of a variant classification pipeline and single page summary for reporting
clinical results of whole genome sequencing.
Immune
Design entered into a
clinical trial collaboration with Genentech, a member of the Roche Group, to evaluate the safety and efficacy of its CMB305 cancer immunotherapy product candidate combined with the investigational cancer immunotherapy atezolizumab in a
randomized Phase 2
trial in patients with soft tissue sarcoma.
Design: A systematic review of the published literature through January 2015 was performed by using sensitive search strategies to identify
randomized controlled
clinical trials that evaluated the effects of fasting on either clinically relevant surrogate outcomes (e.g., weight, cholesterol) or actual
clinical event endpoints [e.g., diabetes, coronary artery disease (CAD)-RSB- and any other studies that evaluated the effects of fasting on
clinical event outcomes.
Design, Setting, and Participants This
randomized clinical trial was conducted at 11 diverse pediatric practices in the Greater Boston area.
A pragmatic cluster
randomized clinical trial of diabetes prevention strategies for women with gestational diabetes:
design and rationale of the Gestational Diabetes» Effects on Moms (GEM) study
Schema Therapy for forensic patients with personality disorders:
Design and preliminary findings of multicenter
randomized clinical trial in the Netherlands.
Daro has completed dozens of multisite evaluations over the past 40 years that have incorporated a range of research
designs, including both
randomized clinical trials and various quasi-experimental
designs.
Fortunately, conducting
randomized trials over the decades, intervention researchers have produced numerous manual - guided, evidence - based treatments (EBTs) for depression, anxiety, and conduct in youth.2 Unfortunately, these treatments have not been incorporated into most everyday
clinical practice.3 - 5 A common view is that the complexity and comorbidity of many clinically referred youths, whose problems and treatment needs can shift during treatment, may pose problems for EBT protocols, which are typically
designed for single or homogeneous clusters of disorders, developed and tested with recruited youths who differ from patients seen in everyday
clinical practice, and involve a predetermined sequence of prescribed session contents, limiting their flexibility.3 - 8 Indeed,
trials testing these protocols against usual care for young patients in
clinical practice have produced mixed findings, with EBTs often failing to outperform usual care.7, 9
The
randomized clinical trial uses a mixed
design with three intervention conditions (one experimental condition and two control conditions) and five assessment points.
The IHDP began in 1985 and was
designed as a eight - site,
randomized clinical trial evaluating early childhood development, center - based education, and home - based family support services, as well as pediatric surveillance in an attempt to reduce the risk for developmental delay, behavioral issues and health problems LBW, PT (≤ 37 weeks gestational age) infants.